FDA Inspection
IDT Biologika GmbHIDT Biologika GmbH – FDA Inspection, Sep 15, 2026
Record Details
This FDA Inspection record concerns IDT Biologika GmbH, with an inspection on September 15, 2026, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · e56b7351-8d76-4d00-acb7-5af6f78c40dc
Inspection Facts
- Inspection number
- 1335726
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of IDT Biologika GmbH
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 8, 2023 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| August 25, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 10, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 8, 2019 | Not classified | Office of Inspections and Investigations | |
| November 22, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for IDT Biologika GmbH
- FDA Inspection 1217129 - 2023-09-08
- FDA Inspection 1277176 - 2023-08-25
- FDA Inspection 1143607 - 2020-09-10
- FDA Inspection 1084145 - 2019-03-08
- FDA Inspection 994505 - 2016-11-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.